Atraric acid ameliorates tributyltin-induced hyperuricemia by attenuating hepatic uric acid production and restoring renal excretion
Food Science and Human Wellness · 30.10.2026
DOI: 10.26599/fshw.2026.9251308 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food Science and Human Wellness, online erschienen am 30.10.2026. Verfasst von Changshun Han und 6 weiteren Autor:innen.
Abstract (Originalsprache)
The global prevalence of hyperuricemia (HUA) is on the rise and is closely linked to various environmental factors. Target risk assessment framework for environmental chemicals (TRAEC) analysis identifies organotin compounds as a notable risk factor for hepatic and renal injury. Nevertheless, their potential association with HUA and the underlying pathological mechanisms remain poorly characterized, and protective interventions are still underexplored. Network pharmacology predicts that atraric acid (AA) may have therapeutic potential in alleviating HUA and related liver and kidney damage. Therefore, we exposed female C57BL/6 mice to an environmentally relevant concentration of tributyltin (TBT) (500 ng/kg/d) for 6 weeks, then administered AA (50, 100 mg/kg/d) for another 6 weeks. Supporting in vitro experiments were also conducted. This study demonstrated that TBT exposure promoted hepatic UA production and inhibited renal UA excretion, leading to HUA and associated liver and kidney injury. AA exhibited an ameliorative effect on TBT-induced HUA and related damage. Mechanistically, we newly identified that the transcription factor muscle-specific enhancer factor 2C (MEF2C) bound to the ATP-binding cassette subfamily G member 2 (ABCG2) gene promoter to enhance its expression. TBT exposure suppressed MEF2C levels and impeded its nuclear translocation in renal tubular epithelial cells, which led to the downregulation of ABCG2 expression and impaired renal UA excretion. By inhibiting the proteasomal degradation of MEF2C in renal tubular epithelial cells, AA upregulated MEF2C protein levels in both the cytoplasm and nucleus, upregulated ABCG2 expression and promoted renal UA excretion. This study first identified and confirmed the risk of TBT-induced HUA, and first reported that AA ameliorated HUA, providing new insights into the prevention and treatment of pollutant-related metabolic disorders.
Zitieren
APA
Han, C., Xue, F., Chen, Z., Ding, X., Zheng, W., He, C., & Zuo, Z. (2026). Atraric acid ameliorates tributyltin-induced hyperuricemia by attenuating hepatic uric acid production and restoring renal excretion. Food Science and Human Wellness. https://doi.org/10.26599/fshw.2026.9251308
Vancouver
Han C, Xue F, Chen Z, Ding X, Zheng W, He C, et al. Atraric acid ameliorates tributyltin-induced hyperuricemia by attenuating hepatic uric acid production and restoring renal excretion. Food Science and Human Wellness. 2026. doi:10.26599/fshw.2026.9251308
BibTeX
@article{Han2026,
author = {Han, Changshun and Xue, Fanzheng and Chen, Zhiyuan and Ding, Xiaoyan and Zheng, Wei and He, Chengyong and Zuo, Zhenghong},
title = {Atraric acid ameliorates tributyltin-induced hyperuricemia by attenuating hepatic uric acid production and restoring renal excretion},
journal = {Food Science and Human Wellness},
year = {2026},
doi = {10.26599/fshw.2026.9251308}
}
EUVIMED